Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a registered legal entity registered in China under 330000000031464, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. The company was incorporated on 1 January 1999 and lists its registered address as Xinchang, China. 5 shareholders are on record for Zhejiang Jingxin Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Zhejiang Jingxin Pharmaceutical Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC.
The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 24% — the largest recorded stake — followed by DFA Emerging Markets Small Cap Series at 8.1%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 24% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| DFA Emerging Markets Small Cap Series | 8.1% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 7.7% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| SPDR Portfolio Emerging Markets ETF | 6.2% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 1.1% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) |
Officers
5
The President & Chairman Of The Board of Zhejiang Jingxin Pharmaceutical Co., Ltd. on record is Lv Gang; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Zhejiang Jingxin Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Zhejiang Jingxin Pharmaceutical Co., Ltd.?
Five shareholders are currently on record for Zhejiang Jingxin Pharmaceutical Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 24% — the largest recorded stake — followed by DFA Emerging Markets Small Cap Series at 8.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Zhejiang Jingxin Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Zhejiang Jingxin Pharmaceutical Co., Ltd. have on record?
5 shareholders are shown on record for Zhejiang Jingxin Pharmaceutical Co., Ltd.. The register reports 10 in total; only the top 5 by holding are shown here.
What is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s company registration number?
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s registration number is 330000000031464, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) in China. Its current status on the register is active.
Is Zhejiang Jingxin Pharmaceutical Co., Ltd. still an active company?
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.
When was Zhejiang Jingxin Pharmaceutical Co., Ltd. incorporated?
Zhejiang Jingxin Pharmaceutical Co., Ltd. was incorporated on 1 January 1999, according to SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).
What is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Zhejiang Jingxin Pharmaceutical Co., Ltd. is Xinchang, China.
Who are the officers/directors of Zhejiang Jingxin Pharmaceutical Co., Ltd.?
The President & Chairman Of The Board of Zhejiang Jingxin Pharmaceutical Co., Ltd. on record is Lv Gang; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Zhejiang Jingxin Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Zhejiang Jingxin Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Zavia's monitoring API can track changes to Zhejiang Jingxin Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Zhejiang Jingxin Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including China, so records like Zhejiang Jingxin Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last synced on 22 September 2026.